NM_001353921.2:c.49A>G
Variant summary
Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The NM_001353921.2(ARHGEF9):c.49A>G(p.Ile17Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000185 in 1,209,553 control chromosomes in the GnomAD database, including 1 homozygotes. There are 48 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_001353921.2 missense
Scores
Clinical Significance
Conservation
Publications
- developmental and epileptic encephalopathy, 8Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae), Orphanet
- X-linked complex neurodevelopmental disorderInheritance: XL Classification: MODERATE Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -16 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_001353921.2. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| ARHGEF9 | NM_001353921.2 | MANE Select | c.49A>G | p.Ile17Val | missense | Exon 2 of 10 | NP_001340850.1 | ||
| ARHGEF9 | NM_001353923.1 | c.67A>G | p.Ile23Val | missense | Exon 2 of 10 | NP_001340852.1 | |||
| ARHGEF9 | NM_001369030.1 | c.28A>G | p.Ile10Val | missense | Exon 3 of 11 | NP_001355959.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| ARHGEF9 | ENST00000671741.2 | MANE Select | c.49A>G | p.Ile17Val | missense | Exon 2 of 10 | ENSP00000500715.1 | ||
| ARHGEF9 | ENST00000253401.10 | TSL:1 | c.28A>G | p.Ile10Val | missense | Exon 2 of 10 | ENSP00000253401.6 | ||
| ARHGEF9 | ENST00000374878.5 | TSL:1 | c.49A>G | p.Ile17Val | missense | Exon 2 of 10 | ENSP00000364012.2 |
Frequencies
GnomAD3 genomes AF: 0.00116 AC: 129AN: 111474Hom.: 1 Cov.: 22 show subpopulations
GnomAD2 exomes AF: 0.000218 AC: 40AN: 183125 AF XY: 0.0000740 show subpopulations
GnomAD4 exome AF: 0.0000865 AC: 95AN: 1098023Hom.: 0 Cov.: 30 AF XY: 0.0000495 AC XY: 18AN XY: 363389 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00116 AC: 129AN: 111530Hom.: 1 Cov.: 22 AF XY: 0.000890 AC XY: 30AN XY: 33718 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not specified Benign:2
not provided Benign:2
Inborn genetic diseases Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.
Developmental and epileptic encephalopathy, 8 Benign:1
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at